About Jason Turner
Jason Turner is a chief executive officer and director at Vantis Vascular.
Jason Turner first appears on SEC filings in 2022.
Experience
This experience comes from Jason Turner's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Turner in the role, so the role may have started earlier or lasted longer.
NI
Nervonik, Inc. Current
Member Board of Directors
2025 – Present
Vantis Vascular, Inc. Current
President and Chief Executive Officer (2022 – Present)
Director
2022 – Present · San Jose, CA
Develops medical devices for cardiologists treating complex blood vessel conditions.
EM
Efemoral Medical Current
Member Board of Directors
2022 – Present
VE
Venclose
Chief Operating Officer
2016 – 2021
CA
CardioDx
Sr Director, Sales Operations
2015 – 2016
EC
Elixir Medical Corporation
Sr. Director, Business Operations and Supply Chain
2014 – 2015
AC
Access Closure
Director, Business Operations
2007 – 2014
VT
VNUS Medical Technologies
Manufacturing Operations
2004 – 2007
Key Colleagues at Startups
The people Jason Turner works with at each company, as listed on that company's latest Form D.
Vantis Vascular, Inc. · Form D, Jul 10, 2026
LP
Len Pinchuk
Director
Frank Saltiel
Chief Clinical Officer and director
Gary McCord
Chief Commercial Officer
Marc Monahan
Chief Financial Officer
Mike Mirizzi
Chief Technology Officer
Tim Fischell
Chief Medical Officer and director